focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Replacement of Shire

27 Dec 2018 15:07

RNS Number : 6048L
Morgan Stanley & Co. Int'l plc
27 December 2018
 

AMENDMENT Section (2a)

 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date dealing undertaken:

20 DECEMBER 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Takeda Pharmaceutical Company Limited

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 ADR

 PURCHASES

 59,000

 171.2100 USD

 171.2100 USD

 

 ADR

 SALES

 121,000

 172.5700 USD

 171.2100 USD

 

 5p ordinary

 PURCHASES

 4,136,907

 45.9559 GBP

 44.9100 GBP

 

 5p ordinary

 SALES

 3,176,495

 45.9500 GBP

 44.4682 GBP

 

 5p ordinary

 PURCHASES

 509,935

 58.2195 USD

 56.1467 USD

 

 5p ordinary

 SALES

 749,784

 58.1780 USD

 56.8026 USD

 

 

 

(b) Cash-settled derivative transactions

 

 Class of

relevant

security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

 ADR

 CFD

 LONG

 51,000

 171.2100 USD

 

 ADR

 CFD

 LONG

 8,000

 171.2100 USD

 

 ADR

 CFD

 LONG

 1,500

 171.9007 USD

 

 ADR

 CFD

 SHORT

 8,000

 171.2100 USD

 

 5p ordinary

 CFD

 LONG

 100,000

 44.4682 GBP

 

 5p ordinary

 CFD

 LONG

 100,000

 44.4682 GBP

 

 5p ordinary

 CFD

 LONG

 87,283

 44.9100 GBP

 

 5p ordinary

 CFD

 LONG

 26,469

 44.9100 GBP

 

 5p ordinary

 CFD

 LONG

 1,846

 44.9100 GBP

 

 5p ordinary

 CFD

 LONG

 14,763

 45.2200 GBP

 

 5p ordinary

 CFD

 LONG

 53,633

 45.2490 GBP

 

 5p ordinary

 CFD

 LONG

 7,962

 45.3049 GBP

 

 5p ordinary

 CFD

 LONG

 1,571

 45.3049 GBP

 

 5p ordinary

 CFD

 LONG

 948

 45.3049 GBP

 

 5p ordinary

 CFD

 LONG

 355

 45.3049 GBP

 

 5p ordinary

 CFD

 LONG

 102,920

 45.3049 GBP

 

 5p ordinary

 CFD

 LONG

 29,990

 45.3049 GBP

 

 5p ordinary

 CFD

 LONG

 656

 45.3097 GBP

 

 5p ordinary

 CFD

 LONG

 498

 45.3097 GBP

 

 5p ordinary

 CFD

 LONG

 20,000

 45.7950 GBP

 

 5p ordinary

 CFD

 LONG

 12,500

 45.7950 GBP

 

 5p ordinary

 CFD

 LONG

 17,500

 45.7950 GBP

 

 5p ordinary

 CFD

 LONG

 60,000

 45.8354 GBP

 

 5p ordinary

 CFD

 LONG

 100,000

 45.8354 GBP

 

 5p ordinary

 CFD

 LONG

 150,000

 45.8354 GBP

 

 5p ordinary

 CFD

 LONG

 90,000

 45.8354 GBP

 

 5p ordinary

 CFD

 LONG

 300,000

 45.8891 GBP

 

 5p ordinary

 CFD

 LONG

 100,000

 45.8891 GBP

 

 5p ordinary

 CFD

 LONG

 31,857

 45.9100 GBP

 

 5p ordinary

 CFD

 LONG

 45,854

 45.9100 GBP

 

 5p ordinary

 CFD

 LONG

 68,500

 45.9500 GBP

 

 5p ordinary

 CFD

 SHORT

 49,584

 44.9100 GBP

 

 5p ordinary

 CFD

 SHORT

 419,310

 45.1792 GBP

 

 5p ordinary

 CFD

 SHORT

 199,861

 45.2087 GBP

 

 5p ordinary

 CFD

 SHORT

 14,763

 45.2200 GBP

 

 5p ordinary

 CFD

 SHORT

 1,899

 45.2205 GBP

 

 5p ordinary

 CFD

 SHORT

 183,404

 45.2454 GBP

 

 5p ordinary

 CFD

 SHORT

 155,028

 45.2566 GBP

 

 5p ordinary

 CFD

 SHORT

 3,333

 45.2898 GBP

 

 5p ordinary

 CFD

 SHORT

 8,389

 45.3095 GBP

 

 5p ordinary

 CFD

 SHORT

 5,452

 45.3367 GBP

 

 5p ordinary

 CFD

 SHORT

 25

 45.4035 GBP

 

 5p ordinary

 CFD

 SHORT

 712,391

 45.4955 GBP

 

 5p ordinary

 CFD

 SHORT

 100,921

 45.5295 GBP

 

 5p ordinary

 CFD

 SHORT

 68,281

 45.5295 GBP

 

 5p ordinary

 CFD

 SHORT

 1,971

 45.5304 GBP

 

 5p ordinary

 CFD

 SHORT

 3,746

 45.5897 GBP

 

 5p ordinary

 CFD

 SHORT

 5,619

 45.5897 GBP

 

 5p ordinary

 CFD

 SHORT

 178,800

 45.5941 GBP

 

 5p ordinary

 CFD

 SHORT

 359

 45.9559 GBP

 

 5p ordinary

 CFD

 LONG

 25,000

 57.3679 USD

 

 5p ordinary

 CFD

 LONG

 15,000

 57.3679 USD

 

 5p ordinary

 CFD

 LONG

 200,000

 58.1439 USD

 

 5p ordinary

 CFD

 LONG

 45,000

 58.1565 USD

 

 5p ordinary

 CFD

 LONG

 65,000

 58.1741 USD

 

 5p ordinary

 CFD

 LONG

 10,000

 58.1741 USD

 

 5p ordinary

 CFD

 LONG

 23,838

 58.1780 USD

 

 5p ordinary

 CFD

 SHORT

 26,474

 57.2693 USD

 

 5p ordinary

 CFD

 SHORT

 121,423

 57.2693 USD

 

 5p ordinary

 CFD

 SHORT

 57,281

 57.2693 USD

 

 5p ordinary

 CFD

 SHORT

 14,822

 57.2693 USD

 

 5p ordinary

 CFD

 SHORT

 60,000

 57.2754 USD

 

 5p ordinary

 CFD

 SHORT

 4,416

 57.4720 USD

 

 5p ordinary

 CFD

 SHORT

 8,584

 57.4720 USD

 

 5p ordinary

 CFD

 SHORT

 350

 58.2195 USD

 

 5p ordinary

 CFD

 SHORT

 17,980

 58.2195 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of

relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(ii) Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 Date of disclosure:

 27 DECEMBER 2018

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERTRBATMBMTBFP
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.